appengine.ai

Artificial Intelligence | Machine Learning | Machine Perception Aegicare | Precision Drug Development Platform


Enterprise, Biotechnology, Healthcare, Pharmaceuticals, Research & Drug Development Palo Alto, CA, United States

Aegicare

Artificial Intelligence | Machine Learning | Machine Perception


Aegicare | Precision Drug Development Platform

Aegicare

Biotechnology, Healthcare, Pharmaceuticals, Research & Drug Development


Palo Alto, CA, United States

Deep learning of multi-omics data helps research and development of precision therapeutic drugs.

Aegicare is a genomic intelligence company empowering precision medicine, from high-throughput diagnosis to innovative therapeutics. With our first-in-class clinical lab and AEGIS genomic intelligence platform powered by cutting-edge natural language processing, bioinformatics, and deep learning algorithms, we make genetic information more affordable and accessible, we facilitate better clinical decisions, and we revolutionize the process for genome-based drug discovery. Nearly 4% of the world’s population are suffering from genetic diseases that do not have a cure, around 80~95% of people need to try multiple drugs in order to find one that’s effective, even more strikingly, millions of people have hospitalized annually due to adverse side effects from medications, resulting in hundreds of thousands of deaths per year. This highlights the critical need for precision medicine.

 

B2B2C, B2B

101 to 250

Series A

$7,800,000

Scaling Up

2017

 
 

Pharmaceuticals
Healthcare
Biotechnology

N/A

Drug Development
Increase Productivity

 
 

Production

Yes

Active

 
 

   Machine Learning
   Machine Perception


Data Optimization

Data Optimization


N/A

 

   Software


N/A


Deep Learning

Deep Learning

 
 
Yang Li


Yang Li
Founder & CEO

Yang Liu


Yang Liu
CTO